• Search
  • Login
  • Register
Menu
  • Last issue
  • Home
  • News
  • CongressUpdate
  • Guidelines
  • Specials
  • Links
  • Reimbursement News
All
  • All
  • BJH articles
  • Blog articles
  • Specials
Forgot Password? Not a member yet? Register here
News > Pharma News

Category

All
  • General
  • Healthy Living
  • Pharma News
  • Health of Tomorrow
  • Viewpoints
  • Art Corner
  • Fundraising
  • Prevention
  • Science
  • Clinical trials
  • Clinical practice
  • Corona
  • Medical Research
  • Health Innovation
  • Art on View
  • Podcasts
  • Therapy
  • Editor's pick
  • Covid-19
  • Society Announcement
  • Reimbursement News
  • Congress News

Specialty

All
  • Alle
  • YESCARTA
  • BEKEMV
  • NPLATE

Pharma News

Chemotherapy-free treatment option to be offered to Chronic lymphocytic leukaemia patients

Read more
subscribe Latest issue All issues Newsletters
Index latest issue
  • INTRODUCTION
  • Advancements in thrombophilia testing: The role of multi-gene panels in venous thromboembolism
  • The role of UBTF-TD mutations in paediatric acute myeloid leukaemia and myelodysplastic syndrome
  • Desensitisation as treatment option in patients with drug hypersensitivity
  • HMB-001: Novel treatment for Glanzmann thrombasthenia
  • Anti-IL6 receptor antibody for the treatment of immune checkpoint-related hemophagocytic lymphohistiocytosis
  • Highlights from EBMT 2025
  • Journal scan
  • New haematology reimbursements in Belgium
Pharma News

Idecabtagene Vicleucel in relapsed and refractory multiple myeloma

Read more
Pharma News

Pembrolizumab versus brentuximab vedotin in relapsed or refractory classical Hodgkin Lymphoma ...

Read more
Pharma News

Flumatinib induces higher rates of deep responses compared to imatinib in CML

Read more
Pharma News

New treatment for thrombocytopenia in chronic liver disease patients introduced in Europe

Read more
Pharma News

FDA grants Glycostem’s oNKord® Orphan Drug Designation for Multiple Myeloma

Read more
Pharma News

Novel CML-treatment asciminib performs as hoped in phase III trial

Read more
Pharma News

Novel treatment for sickle cell disease granted Orphan Drug designation in EU

Read more
Pharma News

Remdesivir gets European approval as first treatment against COVID-19

Read more
Previous 1 2 3 4 5 6 Next
Top

Join our newsletter

  • This field is for validation purposes and should be left unchanged.
  • About BJH
  • Advertisements & sponsoring
  • Vacancies
  • Disclaimer
  • Privacy
  • Contact

BJH is published by Ariez International BV, Westzijde 22, 1506 EE Zaandam, The Netherlands

© BJH 2025